Leukemia, Myeloid, Acute
Showing NaN - NaN of 21
Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine, PDR001, MBG453)
Active, not recruiting
- Leukemia
- +7 more
- Decitabine
- +3 more
-
Boston, Massachusetts
- +10 more
Jan 19, 2023
Leukemia, Myeloid, Acute Trial in Worldwide (Oral Azacitidine, Placebo)
Active, not recruiting
- Leukemia, Myeloid, Acute
- Oral Azacitidine
- Placebo
-
Phoenix, Arizona
- +247 more
Jan 13, 2023
Leukemia, Myeloid, Acute Trial in Worldwide (AG-120, Azacitidine, AG-221)
Active, not recruiting
- Leukemia, Myeloid, Acute
- AG-120
- +2 more
-
Duarte, California
- +72 more
Aug 18, 2022
Leukemia, Myeloid, Acute, MDS Trial in Worldwide (CC-90009)
Recruiting
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
-
New Haven, Connecticut
- +23 more
Aug 1, 2022
Leukemia, Myeloid, Acute, MDS, Leukemia, Myelomonocytic, Chronic Trial in Worldwide (H3B-8800 (RVT-2001))
Recruiting
- Leukemia, Myeloid, Acute
- +2 more
- H3B-8800 (RVT-2001)
-
Stanford, California
- +26 more
Mar 23, 2022
Leukemia, Myeloid, Acute Trial in Worldwide (glasdegib, daunorubicin + cytarabine, azacitidine)
Leukemia, Myeloid, Acute Trial in Worldwide (Cobimetinib, Idasanutlin, Venetoclax)
Completed
- Leukemia, Myeloid, Acute
- Cobimetinib
- +2 more
-
Los Angeles, California
- +16 more
Dec 13, 2021
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Burkitt Lymphoma Trial in United States
Completed
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
- +5 more
- Hematopoietic Umbilical Cord Blood Stem Cell Transplantation
- GVHD prophylaxis
-
Duarte, California
- +15 more
Nov 2, 2021
Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Acute Trial in United States (DS-3201b)
Terminated
- Leukemia, Myeloid, Acute
- Leukemia, Lymphocytic, Acute
-
Boston, Massachusetts
- +5 more
Jun 11, 2021
Connect® Myeloid Disease Registry
Recruiting
- Primary Myelofibrosis
- +2 more
-
Huntsville, Alabama
- +228 more
Mar 30, 2021
Leukemia, Myeloid, Acute Trial in Australia, Korea, Republic of, United States (NLA101, Standard of Care (SOC) chemo)
Terminated
- Leukemia, Myeloid, Acute
- NLA101
- Standard of Care (SOC) chemotherapy
-
La Jolla, California
- +35 more
Mar 25, 2021
Leukemia, Myeloid, Acute Trial in United States (PNK-007, Cyclophosphamide, Fludarabine)
Terminated
- Leukemia, Myeloid, Acute
- PNK-007
- +3 more
-
Boston, Massachusetts
- +6 more
Jul 20, 2020
Leukemia, Myeloid, Acute, MDS Trial in United States (CC-90002)
Terminated
- Leukemia, Myeloid, Acute
- Myelodysplastic Syndromes
-
Phoenix, Arizona
- +5 more
Oct 17, 2018
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Burkitt Lymphoma Trial in United States
Completed
- Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
- +5 more
- Haploidentical Bone Marrow Transplantation
- GVHD prophylaxis
-
Duarte, California
- +16 more
Nov 28, 2017
Leukemia, Myeloid, Acute, Hematologic Tumors Trial in France, United States (Pimasertib)
Terminated
- Leukemia, Myeloid, Acute
- Hematologic Neoplasms
-
Chicago, Illinois
- +8 more
Jul 19, 2017
Leukemia, Myeloid, Acute Trial in Boston, St. Louis, Houston (G-CSF, Plerixafor, Mitoxantrone)
Leukemia, Myeloid, Acute Trial in United States (Troxatylâ„¢ (troxacitabine))
Terminated
- Leukemia, Myeloid, Acute
- Troxatylâ„¢ (troxacitabine)
-
LaJolla, California
- +19 more
Nov 1, 2006